Clinical Trials on Respiratory Hypersensitivity in Australia

Total 2376 results

Pieris Australia Pty Ltd

Completed

Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma

Asthma

Australia
Accenture

Completed

Repeat Dose Safety Study for Compound to Treat Asthma

Asthma

Australia
GlaxoSmithKline

Completed

Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).

Asthma

Australia
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan; Q-Pharm Pty...

Completed

Safety and Blood Level Study of Unit Dose Budesonide (UDB P101)

Asthma

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A First-in-human, Single-ascending-dose Study of IBI3002 in Healthy Participants and Mild to Moderate Asthmatics

Asthma | Healthy Participants

Australia
GlaxoSmithKline

Completed

Pharmacokinetic Profile of Four Formulations of Fluticasone Furoate (FF) Using Unit Dose Dry Powder Inhaler (UD-DPI) Compared With FF ELLIPTA® Presentation

Asthma

Australia
Accenture

Completed

Single Dose Study of GSK1440115 in Patients With Asthma

Asthma

Australia
Egalet Ltd

Completed

Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic Rhinitis

Allergic Rhinitis

Australia
GlaxoSmithKline

Completed

A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers

Asthma

Australia
Telethon Kids Institute
National Health and Medical Research Council, Australia; Sydney Children's... and other collaborators

Completed

Pertussis Immunisation and Food Allergy (PIFA)

Food Allergy

Australia
TFF Pharmaceuticals, Inc.

Completed

Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma

Asthma

Australia
De Motu Cordis
Novotech (Australia) Pty Limited

Not yet recruiting

Study of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants.

Anaphylactic Reaction

Australia
GlaxoSmithKline

Completed

Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.

Asthma

Australia
Novartis

Completed

Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity

Allergic Rhinitis

Australia
Sydney Children's Hospitals Network

Completed

Role of Technology in Improving Asthma Management In School Staff

Asthma in Children

Australia
GlaxoSmithKline

Completed

A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol

Asthma

Australia
GlaxoSmithKline

Completed

ROTAHALER Device Optimization Study

Asthma

Australia
Bayside Health

Completed

A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy

Asthma | Allergic Rhinitis

Australia
GlaxoSmithKline

Completed

To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma

Asthma

Australia
Syneos Health
Shanghai Novamab Biopharmaceuticals Co. Ltd.

Terminated

First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036

Asthma

Australia
GlaxoSmithKline

Completed

A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers

Asthma

Australia
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

Completed

Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study (GPAC)

Asthma | Allergic Sensitization

United States, Australia
Bayside Health

Completed

Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis

Allergic Rhinitis

Australia
Community and Patient Preference Research Pty Ltd
Seqirus; Glenmark Pharmaceuticals S.A.

Completed

Patient Satisfaction and Sensory Attributes Allergic Rhinitis Nasal Spray

Allergic Rhinitis

Australia
AstraZeneca

Completed

Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)

Asthma

France, South Africa, Spain, Australia, Belgium
Community and Patient Preference Research Pty Ltd
Seqirus Limited; Glenmark Pharmaceuticals

Withdrawn

Impact of RYALTRIS® Nasal Spray on Patients' Reported Outcomes

Allergic Rhinitis

Australia
AstraZeneca

Completed

Be SMART NIS, Moderate to Servere Asthma Patient Observation

Asthma

Austria
Inimmune Corporation
Avance Clinical Pty Ltd.

Recruiting

Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.

Allergic Rhinitis | Allergic Rhinitis Due to Weed Pollen

Australia
Karl Landsteiner Institute for Clinical and Experimental...
Universitätsklinik für Innere Medizin II, Pulmologie

Completed

UNCOVER - a Non-interventional Study to Investigate Undiagnosed Severe Asthma

Asthma

Austria
GlaxoSmithKline

Completed

A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine

Rhinitis, Allergic, Perennial and Seasonal

Australia
De Motu Cordis
Novotech (Australia) Pty Limited

Completed

Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults

Anaphylactic Reaction

Australia
Fresenius Medical Care Deutschland GmbH

Completed

Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study) (ESPIRA)

Allergic Asthma

Austria
EURRUS Biotech GmbH

Completed

Study to Assess Pharmacokinetics, Safety, and Tolerability of XC-8

Asthma

Austria, Germany
Murdoch Childrens Research Institute

Not yet recruiting

Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy (HILO)

Peanut Allergy

Australia
GlaxoSmithKline

Completed

Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response

Asthma

Sweden, Australia, New Zealand
Restech Srl

Recruiting

Self-Management Of Asthma By Forced Oscillation Technique (PIANOFORTE)

Asthma

Italy, Australia, France
Bayside Health
The Alfred

Unknown

Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease

Asthma | Cystic Fibrosis | Bronchiolitis Obliterans | Lung Transplantation

Australia
GlaxoSmithKline

Completed

Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.

Asthma

Australia, New Zealand
Medical University of Graz
Ludwig Boltzmann Institute for Lung Vascular Research

Completed

FeNO After Hypoxia in Asthma Patients

Asthma

Austria
Gilead Sciences

Completed

Study to Investigate Effects of CAL-101 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber

Allergic Rhinitis

Austria
Oxagen Ltd

Completed

A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis

Allergic Rhinitis

Austria
Gilead Sciences

Completed

Study to Investigate Effects of CAL-263 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber

Allergic Rhinitis

Austria
University of Melbourne

Active, not recruiting

The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants (PEBBLES)

Asthma | Eczema | Allergy;Food

Australia
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma

Asthma

United States, Australia, New Zealand, South Africa
University of Newcastle, Australia
GlaxoSmithKline

Unknown

Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab".

Asthma | Eosinophilic Asthma

Australia
GlaxoSmithKline

Completed

A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)

Rhinitis, Allergic, Seasonal

Austria
Equillium
Biocon Limited; Equillium AUS Pty Ltd

Completed

A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma (EQUIP)

Asthma

New Zealand, Australia
GlaxoSmithKline

Completed

Intranasal SB-705498 in Allergic Rhinitis (AR) Patients

Rhinitis

Austria
Medical University of Graz
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Active, not recruiting

Integrative Omics Approach to Allergic Rhinitis (IntegOmics)

Allergic Rhinitis

Austria
GlaxoSmithKline

Completed

A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber

Allergic Rhinitis | Rhinitis, Allergic, Perennial

Austria

3

Subscribe